A BILL 
To provide for a pathway for chemically synthesized insulin 
to be approved under an abbreviated new drug applica-
tion submitted under the Federal Food, Drug, and Cos-
metic Act, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Market Access for Ge-
4
neric Insulin Competition’’ or the ‘‘MAGIC Act’’. 
5
01:11 Sep 10, 2019
H4244
2 
•HR 4244 IH
SEC. 2. PROVIDING FOR A PATHWAY FOR APPROVAL OF 
1
CHEMICALLY SYNTHESIZED INSULIN UNDER 
2
AN ABBREVIATED NEW DRUG APPLICATION. 
3
(a) IN GENERAL.—Section 7002(e)(2) of the Patient 
4
Protection and Affordable Care Act (42 U.S.C. 262 note) 
5
is amended— 
6
(1) in subparagraph (B), by redesignating 
7
clauses (i) and (ii) as subclauses (I) and (II), respec-
8
tively, and moving the margins of such subclauses 
9
(as so redesignated) two ems to the right; 
10
(2) in subparagraph (A), by striking ‘‘such bio-
11
logical product’’ and inserting ‘‘(i) such biological 
12
product’’; 
13
(3) by redesignating subparagraph (B) as 
14
clause (ii) and moving the margin of such clause (as 
15
so redesignated) two ems to the right; 
16
(4) in clause (ii) (as so redesignated), by strik-
17
ing the period at the end and inserting ‘‘; or’’; and 
18
(5) by adding at the end the following: 
19
‘‘(B) notwithstanding paragraphs (3) and 
20
(4), the application is submitted under sub-
21
section (j) of such section for chemically syn-
22
thesized insulin or any analogue of chemically 
23
synthesized insulin for which the listed drug is 
24
a biological product that is, pursuant to para-
25
01:11 Sep 10, 2019
H4244
3 
•HR 4244 IH
graph (4), deemed to be licensed under section 
1
351 of the Public Health Service Act.’’. 
2
(b) EFFECTIVE DATE.—The amendments made by 
3
this section shall apply with respect to applications sub-
4
mitted on or after January 1, 2020. 
5
Æ 
01:11 Sep 10, 2019
H4244
